CROI 2020 Abstract eBook

Abstract eBook

Keyword Index

-N- N6LS 508 NA-ACCORD 628 N-Acetylcysteine 741

Latency 26, 74, 79, 279, 304, 305, 306, 307, 311, 314, 330, 331, 335, 340, 355, 356, 357, 428 • establishment 166 • model 306 • reversing agents 38, 320, 331, 333, 354, 355, 356 Latent • class analysis 891 • HIV-1 reservoir 276, 306, 317, 322, 329, 330, 334, 336, 355, 360, 370, 385, 814 • profile analysis 304, 814 • tuberculosis 728, 730 Latin America 857, 868 Learning 438 LEDGF 26 LEDGINs 26 Ledipasvir/sofosbuvir 576 Leprosy 450 Levonorgestrel 1064 Life expectancy 151, 868 Linkage and retention 570, 779, 955, 1073, 1104, 1122, 1138 Lipidomics 237, 238, 796 Lipids 237, 827 Lipodystrophy 658 Liver 545, 549 • biopsies 128 • disease progression 122, 128 • disease 545, 553, 554, 559, 616 • elastography 541 • fibrosis 128, 543, 544, 552, 609 • stiffness 122, 550, 569, 582 • transplantation 193 Liver-related death 554, 578, 579 Local transmission 921 Long-acting 34, 467, 469, 470, 472, 473, 482, 504, 507, 532, 775, 1000 Longitudinal multivariate normative comparisons 401 Longitudinal study 85, 122, 126, 147, 303, 313, 882

Memory CD4T cells 362, 368 Memory 115, 387 Men 49, 142, 860, 955, 960 • of color who have sex with men 949, 983, 1005 • who have sex with men 48, 124, 145, 146, 194, 213, 538, 564, 594, 597, 598, 617, 622, 703, 852, 858, 861, 874, 878, 905, 907, 914, 916, 917, 918, 936, 938, 963, 964, 979, 985, 987, 989, 991, 992, 993, 997, 998, 1005, 1014, 1018, 1025, 1027, 1031, 1048, 1051, 1067, 1072, 1097, 1113 • who have sex with women 1045 Mendelian randomization 80 Mesenchymal stem cells 198 Mesenteric lymph nodes 197 Meta-analysis 738 Metabolic syndrome 81, 223 Metabolism 229 Metabolomics 224, 248, 413, 793, 802 Metformin 169, 229 Methadone 1140 Methamphetamine 601, 703 Methotrexate 285 Mexico 274 MF59 288 Microbial translocation 223, 231, 232, 236 Microbicide 997, 998, 999, 1015 Microbiome 208, 216, 226, 227, 284, 459, 797, 805, 1039, 1059, 1060, 1061 Microbiota 211, 213, 223, 224, 226, 228, 229, 284, 1060 Microepidemics 1093, 1144 Microglia 420, 422 MicroRNA 552 Microvesicles 208 Meningitis 756 Menopause 669 Mental health 703, 836, 898, 899 Meropenem 732 Mobile phone use 1137, 1146 Mobile technology 44, 1137 Mobility 705, 849, 923, 1102 Modeling 384, 403, 448, 462, 471, 733, 953, 988, 1076, 1092, 1096 Molecular epidemiology 124, 598, 907, 910, 914, 916, 922, 927, 932 Monitoring 35 Monoclonal antibody 508 Monocyte activation 235, 584, 641, 730 Monocytes 638, 673, 730 Morbidity 876 Mortality 67, 151, 152, 556, 578, 580, 664, 685, 736, 863, 869, 870, 871, 872, 873, 874, 875, 876, 893, 894, 895, 899, 1108 Mother-to-child transmission 181, 294 Motivation 1038 Motivational interviewing 786 Mouse model 191 Mozambique 627, 873, 957 MRI 33, 400, 838 Mucosal 226 • HIV-1 transmission 213, 1039 • immune response 289 • immunity 233, 332 • immunology 214, 247, 251, 459 • protection 252 Multi-class resistance 522, 523 Migrants 918, 920, 921 Migration 849, 919, 1078 Minimally invasive HIV testing 968 Minority variants 519 MiRNA 584 Misdiagnosis 953, 965 Missed visit 902 Mitochondria 196, 230, 416, 663, 704, 715, 716 MitoQ 663 MK-8591 89 MMF 340

Namibia 923, 1078 Nanomedicine 467 Nanoparticle 280 NASH 547 Natural immunity 725 Natural killer cells 30, 115, 200, 251, 252, 280, 281, 384, 587, 809 Navigation 988 Near-full-length HIV-1 sequencing 928

Neisseria gonorrhoeae 1053, 1054 Neonatal prophylaxis regimen 788 Neonatal 775 Neonates 839, 842 • network 912 • analysis 147, 199, 913, 923 • homophily 917 • models 1126

Neural tube defect 792 Neuroactive steroids 413 Neurocognition 388, 394, 396, 398, 400, 402, 409, 410, 412, 438, 553 Neurodevelopment 838 Neurofilament light chain 404 NeuroHIV 400, 405, 418, 837 Neuroimaging 29, 375, 388, 392, 394, 395, 396, 398, 418, 798, 837, 838 Neuroinflammation 326, 391, 422 Neuronal injury 29, 326 Neuropathogenesis 411, 429 Neuropsychiatric 388, 395, 415, 436, 441, 442, 799 Neurosyphilis 1050, 1051 New infections 861 New to HIV care 504 Next generation sequencing (NGS) 269, 356, 421, 528, 536, 561, 634, 930, 935 Nigeria 681 Nitazoxanide 610 NLRX1 169 NNRTI 473, 474, 501, 531, 999 Non alcoholic liver disease 128 Non communicable diseases 558, 660, 687, 742, 1091 Non-AIDS comorbidity 695, 711 Non-AIDS defining cancer 632 Non-AIDS events 152, 241, 242, 243 Non-alcoholic fatty liver disease 543, 544, 546, 547 Neurotoxicity 388 Neutralization 383 Neutralizing antibodies 114, 525 Neutrophils 445 Nevirapine prophylaxis 788

Long-term ART 136, 218, 303 Long-term nonprogressor 825 Lopinavir 821 Lopinavir/ritonavir 799 Loss to follow-up 873, 1071, 1105, 1106 Low- and middle-income countries 133, 310 Low birth weight 843 Low resource settings 517 Low-level viremia 152, 712, 970 LTR 369 Lung cancer 625, 697 Lung function 85, 415, 696 Lungs 268, 332 Lymph node 72, 273, 293, 315, 317 Lymphocyte phenotypes 330, 332 Lymphoid tissue 119, 277, 329 Lymphoma 630 -M- M184V 93, 485, 509 Macaque model 88, 286, 420, 731 Machine learning 32, 390, 649, 913, 1137 Machine-learning 287, 1137 Macrophages 30, 190, 209, 237, 323 Macrophage tropism 323 MACS 401 Magnetic resonance elastography 553 Magnetic resonance imaging 72, 389, 399, 400 Maintenance therapy 34, 490, 494 Malaria 137 Malawi 516, 624, 765, 784 Male partners 624, 959, 1015

Non-B subtypes 919 Non-coding RNA 216 Noncommunicable diseases 687, 712, 1094 Non-Hodgkin lymphoma 630 Nonhuman primates 87, 118, 261, 278, 293, 294 Non-liver-related death 578 NONMEM 452 Non-progressor 171 North America 71, 650, 680

Keyword Index

NRTI 501, 530, 676, 716 Nuclear envelope 165 Nuclear import 22, 165 Nucleic acid test 954 Nucleocapsid 167 -O-

Male sex workers 879 Malignancies 630, 754 Mannoprotein 750

Obesity 221, 541, 773, 801 Observational studies 499 On demand PrEP 1006 Oncogenesis 255 Opioid 600 • agonist therapy 1145 • overdose 887 • use 235, 559, 599, 780, 1140, 1141 Opportunistic infection 500, 725, 752, 754, 757 Optimal allocation 1128 Optimization strategies 940 Option B+ 768 Oral fluid 956 Oral transmission 205 Oraquick 968 Origin of infection 921 Outcomes 656, 746, 1104

Mapping 925 Maraviroc 842 Marginal structural modeling 869 Marijuana 780, 835 Maternal and child health 793 Maternal and infant adverse events 130 MaternalTB 144 Mathematical model 513, 901, 1095, 1098, 1126, 1129, 1144 Maturation inhibitors 505 Mediators 638 Medicaid 884, 1012 Medicare 1012 Medication-assisted treatment 887 Membrane Fusion 21

Multidisciplinary team 767 Multilevel modeling 1127 Multimodal MRI 397 Multimonth prescribing 43, 1088 Multiple imputation 863 Multipurpose prevention 1000 Multistate models 873 Muscle 704, 705, 820 Mycobacteria 731, 735 Myelin 33 Myocardial infarction 644, 650, 659, 664

CROI 2020 465